{"id":80382,"date":"2025-11-14T08:36:34","date_gmt":"2025-11-14T08:36:34","guid":{"rendered":"https:\/\/www.europesays.com\/se\/80382\/"},"modified":"2025-11-14T08:36:34","modified_gmt":"2025-11-14T08:36:34","slug":"subutex-forsvinner-fran-sverige","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/80382\/","title":{"rendered":"Subutex f\u00f6rsvinner fr\u00e5n Sverige"},"content":{"rendered":"<p><a data-test-tag=\"internal-link\" href=\"https:\/\/www.aftonbladet.se\/av\/jonathan-norberg\" class=\"hyperion-css-13ns1rr\" rel=\"nofollow noopener\" target=\"\" aria-label=\"Se alla artiklar av Jonathan Norberg\"><img decoding=\"async\" class=\"image-asset hyperion-css-n6kkq1\" data-test-tag=\"image-asset\" src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2025\/11\/1763109392_379_0c83c629-f6e4-476f-895e-11ef9702f091\"  alt=\"\"  loading=\"lazy\" fetchpriority=\"auto\" style=\"aspect-ratio:1900 \/ 1900\"\/><\/a>share-arrowDela<\/p>\n<p>unsaveSpara<\/p>\n<p>expand-left<\/p>\n<p>helsk\u00e4rm<img decoding=\"async\" class=\"image-asset hyperion-css-u06ts1\" data-test-tag=\"image-asset\" src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2025\/11\/73312bc3-253f-4c0a-95ac-8e2cc911cc72\"  alt=\"\"  loading=\"eager\" fetchpriority=\"high\" style=\"aspect-ratio:1900 \/ 1048\"\/> Foto: Isaac Lee \/ Getty Images<\/p>\n<p class=\"hyperion-css-1shl3oz\" data-test-tag=\"lead-text\">Det fr\u00e4msta l\u00e4kemedlet mot opioidberoende f\u00f6rsvinner helt fr\u00e5n Sverige n\u00e4sta \u00e5r.<\/p>\n<p class=\"hyperion-css-1shl3oz\" data-test-tag=\"lead-text\">Beskedet har lett till ett n\u00f6dl\u00e4ge inom missbruksv\u00e5rden.<\/p>\n<p class=\"hyperion-css-1shl3oz\" data-test-tag=\"lead-text\">\u2013\u00a0Det blev en ganska obehaglig \u00f6verraskning, s\u00e4ger beroendel\u00e4karen Joar Guterstam.<\/p>\n<p class=\"hyperion-css-1v9qo5x\">Den orov\u00e4ckande nyheten kom under g\u00e5rdagen.<\/p>\n<p class=\"hyperion-css-1v9qo5x\">I ett mejl som g\u00e5tt ut till v\u00e5rdgivare runt om i landet meddelar l\u00e4kemedelsf\u00f6retaget Indivior att de helt l\u00e4mnar den svenska marknaden \u2013 med omedelbar verkan.<\/p>\n<p class=\"hyperion-css-1v9qo5x\">Detta inneb\u00e4r att det mest anv\u00e4nda l\u00e4kemedlet mot opioidberoende, injektionsv\u00e4tskan Subutex, kan f\u00f6rsvinna fr\u00e5n <a data-test-tag=\"internal-link\" href=\"https:\/\/www.aftonbladet.se\/tagg\/sverige\" class=\"hyperion-css-15jkft9\" rel=\"nofollow noopener\" target=\"\" aria-label=\"Sverige\">Sverige<\/a> om bara n\u00e5gra veckor.<\/p>\n<p class=\"hyperion-css-1v9qo5x\">\u2013\u00a0Jag blev v\u00e4ldigt f\u00f6rv\u00e5nad, det h\u00e4r \u00e4r en typ av behandling som \u00f6kat ganska mycket och \u00e4r det senaste preparatet som har godk\u00e4nts. Pl\u00f6tsligt f\u00f6rsvinner det, s\u00e4ger Joar Guterstam, forskare och beroendel\u00e4kare p\u00e5 Karolinska Institutet.<\/p>\n<p>expand-left<\/p>\n<p>helsk\u00e4rm<img decoding=\"async\" class=\"image-asset hyperion-css-u06ts1\" data-test-tag=\"image-asset\" src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2025\/11\/6ef4bc6d-1404-45ee-a04f-e4ced1d9b469\"  alt=\" Beroendel\u00e4karen Joar Guterstam\"  loading=\"eager\" fetchpriority=\"high\" style=\"aspect-ratio:1181 \/ 818\"\/>Beroendel\u00e4karen Joar Guterstam Foto: Karolinska Institutet.\u201dM\u00e5ste prioritera om helt\u201d<\/p>\n<p class=\"hyperion-css-1v9qo5x\">Subutex ges i form av en injektion en g\u00e5ng i m\u00e5naden och mildrar bland annat abstinenssymtom. De som behandlas med l\u00e4kemedlet lever ofta i ett heroinberoende, och f\u00e5r behandlingen under \u00f6vervakning.<\/p>\n<p class=\"hyperion-css-1v9qo5x\">N\u00e5got likv\u00e4rdigt l\u00e4kemedel finns i\u00a0dag inte i Sverige, enligt Joar Guterstam.<\/p>\n<p class=\"hyperion-css-1v9qo5x\">\u2013\u00a0Det h\u00e4r blir ju en n\u00f6dsituation. Vi m\u00e5ste prioritera om helt och snabbt pr\u00f6va ut alternativ f\u00f6r patienterna, s\u00e4ger han.<\/p>\n<p>expand-left<\/p>\n<p>helsk\u00e4rm<img decoding=\"async\" class=\"image-asset hyperion-css-u06ts1\" data-test-tag=\"image-asset\" src=\"https:\/\/www.europesays.com\/se\/wp-content\/uploads\/2025\/11\/bb36a377-8cae-47a1-8c33-29b9403b08ca\"  alt=\"Subutex finns \u00e4ven som tabletter, men den m\u00e5ste tas varje dag. \u201dEtt krux med den h\u00e4r patientgruppen \u00e4r att beroendev\u00e5rden beh\u00f6ver ha kontroll \u00f6ver behandlingen\u201d, s\u00e4ger Joar Gutestam.\"  loading=\"eager\" fetchpriority=\"high\" style=\"aspect-ratio:1900 \/ 1267\"\/>Subutex finns \u00e4ven som tabletter, men den m\u00e5ste tas varje dag. \u201dEtt krux med den h\u00e4r patientgruppen \u00e4r att beroendev\u00e5rden beh\u00f6ver ha kontroll \u00f6ver behandlingen\u201d, s\u00e4ger Joar Gutestam. Foto: Anders Wiklund\/TT<\/p>\n<p class=\"hyperion-css-1v9qo5x\">Ett alternativ skulle kunna vara tabletter som inneh\u00e5ller samma substans. Men till skillnad fr\u00e5n Subutex beh\u00f6vs de tas en g\u00e5ng om dagen, n\u00e5got som kan komma med sv\u00e5ra utmaningar.<\/p>\n<p class=\"hyperion-css-1v9qo5x\">\u2013\u00a0Det kan ju fungera men det \u00e4r mycket st\u00f6kigare. Ett krux med den h\u00e4r patientgruppen \u00e4r att beroendev\u00e5rden beh\u00f6ver ha kontroll \u00f6ver behandlingen. Med Subutex tar man en spruta i m\u00e5naden och sen \u00e4r man fri. Daglig tablettbehandling kr\u00e4ver mycket mer kontroll, s\u00e4ger Joar Guterstam.<\/p>\n<p>\u201dStor trygghet f\u00f6r sk\u00f6ra m\u00e4nniskor\u201d<\/p>\n<p class=\"hyperion-css-1v9qo5x\"><a data-test-tag=\"internal-link\" href=\"https:\/\/www.aftonbladet.se\/tagg\/lakemedelsverket\" class=\"hyperion-css-15jkft9\" rel=\"nofollow noopener\" target=\"\" aria-label=\"L\u00e4kemedelsverket\">L\u00e4kemedelsverket<\/a> bekr\u00e4ftar att Subutex \u00e4r p\u00e5 v\u00e4g bort fr\u00e5n Sverige.<\/p>\n<p class=\"hyperion-css-1v9qo5x\">\u2013\u00a0Eftersom det \u00e4r \u00e4r nya uppgifter \u00e4ven f\u00f6r oss s\u00e5 har vi inte hunnit utreda dem \u00e4nnu, s\u00e4ger Maria Wanrud, gruppchef p\u00e5 enheten f\u00f6r L\u00e4kemedelsverket.<\/p>\n<p class=\"hyperion-css-1v9qo5x\">Tekniskt sett m\u00e5ste myndigheten godk\u00e4nna att ett l\u00e4kemedelsf\u00f6retag avregistrerar sig fr\u00e5n den svenska marknaden. De har d\u00e4remot ingen praktisk m\u00f6jlighet att tvinga ett f\u00f6retag att forts\u00e4tta leverera l\u00e4kemedel.<\/p>\n<p class=\"hyperion-css-1v9qo5x\">\u2013\u00a0V\u00e5r initiala bed\u00f6mning \u00e4r att det finns alternativ som inte \u00e4r av helt samma styrka men som borde g\u00e5 att anv\u00e4nda, s\u00e4ger Maria Wanrud.<\/p>\n<p class=\"hyperion-css-1v9qo5x\">Trots detta k\u00e4nner Joar Guterstam oro f\u00f6r att en redan utsatt patientgrupp nu kommer f\u00e5 det \u00e4nnu sv\u00e5rare.<\/p>\n<p class=\"hyperion-css-1v9qo5x\">\u2013\u00a0Det finns andra l\u00e5ngverkande alternativ, men inget som \u00e4r precis likadant. Det h\u00e4r \u00e4r ett v\u00e4ldigt individuellt utpr\u00f6vat l\u00e4kemedel och en stor trygghet f\u00f6r ganska sk\u00f6ra m\u00e4nniskor. Det g\u00f6r det till en ganska desperat situation, s\u00e4ger han.<\/p>\n<p class=\"hyperion-css-1v9qo5x\">Aftonbladet har s\u00f6kt Indivior.<\/p>\n","protected":false},"excerpt":{"rendered":"share-arrowDela unsaveSpara expand-left helsk\u00e4rm Foto: Isaac Lee \/ Getty Images Det fr\u00e4msta l\u00e4kemedlet mot opioidberoende f\u00f6rsvinner helt fr\u00e5n&hellip;\n","protected":false},"author":2,"featured_media":80383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[22,23,26,27,17,21,24,25,28,29,15,16,18,34,31,33,32,30,19,20],"class_list":{"0":"post-80382","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-rubriker","8":"tag-breaking-news","9":"tag-breakingnews","10":"tag-featured-news","11":"tag-featurednews","12":"tag-headlines","13":"tag-huvudnyheter","14":"tag-latest-news","15":"tag-latestnews","16":"tag-main-news","17":"tag-mainnews","18":"tag-news","19":"tag-nyheter","20":"tag-rubriker","21":"tag-se","22":"tag-svenska","23":"tag-sverige","24":"tag-sweden","25":"tag-swedish","26":"tag-top-stories","27":"tag-topstories"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115547143376650485","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/80382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=80382"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/80382\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/80383"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=80382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=80382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=80382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}